Home > Insider Trading > Filing (0001140361-15-001670)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1379006	Nanoviricides Inc.	NNVC	Services-Commercial Physical & Biological Research (8731)	760674577

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1513285	Anil Diwan	135 Wood Street West Haven CT 06516	President	Yes	Yes	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2015-01-12	3,000	$2.62	2,061,918	No	4	P	Direct
Common Stock	Acquisiton	2015-01-12	3,000	$2.63	2,064,918	No	4	P	Direct
Common Stock	Acquisiton	2015-01-13	5,000	$2.60	2,069,918	No	4	P	Direct
Common Stock	Acquisiton	2015-01-13	5,000	$2.75	2,074,918	No	4	P	Direct
Common Stock	Acquisiton	2015-01-12	7,392	$2.71	2,082,310	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Footnotes

Includes 285,714 shares of common stock issuable upon exercise of options held by Dr. Diwan that are currently exercisable. Does not include 16,531,429 shares owned by TheraCour Pharma, Inc. (after calculating the Preferred Series A convertible as converted), over which Dr. Diwan holds voting and dispositive power. Does not include 500,000 shares of the Company's Series A Convertible Preferred Stock (the "Series A") which votes at the rate of nine shares of Common Stock per each share of Series A and is convertible into three and one half shares of Common Stock upon a change in control of the Company or upon achieving certain trading prices of the Common Stock (the "Series A Preferred Stock").